Synthetic
Biology
Palifosfamide
MATISSE Trial
MATISSE Trial
Now enrolling patients with extensive-stage small cell lung cancer (SCLC) in an adaptive Phase 3
trial, MATISSE. More info >
Recent
News
News
Stay
Informed
Informed